Published in Exp Cell Res on September 01, 1972
Complete replacement of serum by albumin, transferrin, and soybean lipid in cultures of lipopolysaccharide-reactive B lymphocytes. J Exp Med (1978) 5.45
Transferrin receptor induction in mitogen-stimulated human T lymphocytes is required for DNA synthesis and cell division and is regulated by interleukin 2. Proc Natl Acad Sci U S A (1983) 4.01
Monoclonal antibody to transferrin receptor blocks transferrin binding and inhibits human tumor cell growth in vitro. Proc Natl Acad Sci U S A (1982) 2.42
Control of cloning of normal human T lymphocytes by transferrin, albumin and different lectins. Clin Exp Immunol (1978) 1.13
Electron spin resonance study of changes during the development of a mouse myeloid leukaemia. I. Paramagnetic metal ions. Br J Cancer (1975) 0.99
Mechanisms of inhibition of mononuclear cell activation by the iron-chelating agent desferrioxamine. Immunology (1990) 0.98
Mitogen activation induces the enhanced synthesis of two heat-shock proteins in human lymphocytes. J Cell Biol (1988) 0.97
Selection of cell lines resistant to anti-transferrin receptor antibody: evidence for a mutation in transferrin receptor. Mol Cell Biol (1984) 0.97
Transferrin synthesis by inducer T lymphocytes. J Clin Invest (1986) 0.96
Role of transferrin, Fe, and transferrin receptors in myeloid leukemia cell growth. Studies with an antitransferrin receptor monoclonal antibody. J Clin Invest (1985) 0.93
Transferrin is required for early T-cell differentiation. Immunology (2004) 0.89
Immunoregulation by low density lipoproteins in man. Inhibition of mitogen-induced T lymphocyte proliferation by interference with transferrin metabolism. J Clin Invest (1984) 0.89
Depression of lymphocyte response to phytohaemagglutinin in the presence of plasma from children with acute protein energy malnutrition. Clin Exp Immunol (1975) 0.86
The impact of HIV-1 infection and exposure on natural killer (NK) cell phenotype in Kenyan infants during the first year of life. Front Immunol (2012) 0.86
Iron in joint inflammation. Ann Rheum Dis (1993) 0.84
A lipophilic iron chelator can replace transferrin as a stimulator of cell proliferation and differentiation. J Cell Biol (1984) 0.81
Elevated binding activity of CD8+ cells with phytohaemagglutinin by asbestos fibre in vitro. Clin Exp Immunol (1990) 0.75
Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol (1982) 43.81
Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med (1990) 11.57
Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med (1980) 6.12
Annual hazard rates of recurrence for breast cancer after primary therapy. J Clin Oncol (1996) 4.92
Estrogen replacement therapy in breast cancer survivors. A time for change. Breast Cancer Committees of the Eastern Cooperative Oncology Group. JAMA (1994) 4.01
Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med (1995) 3.83
The metabolism of basic proteins in HeLa cell nuclei. Proc Natl Acad Sci U S A (1966) 2.42
Control of histone synthesis in HeLa cells. Biochim Biophys Acta (1973) 2.41
An early alteration in the phospholipid metabolism of lymphocytes by phytohemagglutinin. Proc Natl Acad Sci U S A (1968) 2.37
Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. J Clin Oncol (1999) 2.22
Histone synthesis in vitro on HeLa cell microsomes. The nature of the coupling to deoxyribonucleic acid synthesis. J Biol Chem (1969) 2.20
Lymphocytes in Whipple's disease. Lancet (1968) 2.06
Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer. Hum Pathol (1992) 2.05
Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer. J Clin Oncol (1995) 2.02
Myelodysplastic syndrome and acute nonlymphocytic leukemia secondary to mitolactol treatment in patients with breast cancer. J Clin Oncol (1989) 2.02
Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer. J Clin Oncol (1991) 1.91
An assay for the mitogenic activity of phytohemagglutinin preparations. Blood (1965) 1.73
A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy. Cancer (1978) 1.71
Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study. N Engl J Med (1989) 1.70
The role of radiotherapy in the management of operable locally advanced breast carcinoma: results of a randomized trial by the Eastern Cooperative Oncology Group. Cancer (1997) 1.60
Adjuvant tamoxifen versus placebo in elderly women with node-positive breast cancer: long-term follow-up and causes of death. J Clin Oncol (1993) 1.55
HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma. J Clin Oncol (1992) 1.55
Selective retrieval of biotin-labeled cells using immobilized avidin. Exp Cell Res (1976) 1.52
Synergistic action of phorbol esters in mitogen-activated bovine lymphocytes. Exp Cell Res (1974) 1.51
Induction of ribonucleic acid synthesis in human leucocytes by phytohemagglutinin. Biochim Biophys Acta (1966) 1.50
A nuclear system for DNA replication from synchronized HeLa cells. Biochim Biophys Acta (1968) 1.46
Dna synthesis in isolated HeLa nuclei. A system for continuation of replication in vivo. Eur J Biochem (1973) 1.45
Methotrexate pneumonitis: case report and review of the literature. Thorax (1972) 1.38
Susceptibility of human lymphocyte populations to infection by herpes simplex virus. Immunology (1977) 1.37
Biochemical events in the animal cell cycle. Fed Proc (1970) 1.33
Histone synthesis in vitro by cytoplasmic microsomes from HeLa cells. Science (1969) 1.33
Thymidine kinase activity in synchronized HeLa cell cultures. Biochem Biophys Res Commun (1965) 1.33
Rapid stimulation of phospholipid metabolism in bovine lymphocytes by tumor-promoting phorbol esters. Cancer Res (1978) 1.32
Biological markers in breast carcinoma. I. Incidence of abnormalities of CEA, HCG, three polyamines, and three minor nucleosides. Cancer (1975) 1.30
Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys (1998) 1.29
Affinity chromatography of heme-binding proteins: an improved method for the synthesis of hemin-agarose. Anal Biochem (1982) 1.29
Effect of prednisolone on synthesis of DNA and RNA by human lymphocytes in vitro. Nature (1967) 1.29
Bone mineral density in women with breast cancer treated with adjuvant tamoxifen for at least two years. Breast Cancer Res Treat (1988) 1.29
Hemin-mediated oxidative degradation of proteins. J Biol Chem (1984) 1.28
Comparison of induction chemotherapies for metastatic breast cancer. An Eastern Cooperative Oncology Group Trial. Cancer (1982) 1.27
Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group. J Clin Oncol (1989) 1.25
Biological markers in breast carcinoma. III. Clinical correlations with carcinoembryonic antigen. Cancer (1977) 1.23
Quantitative studies of phytohemagglutinin-induced DNA and RNA synthesis in normal and agammaglobulinemic leukocytes. J Exp Med (1967) 1.23
Displacement of estradiol from estrogen receptors by simple alkyl phenols. Endocrinology (1978) 1.23
Survival advantage of adjuvant chemotherapy in high-risk node-negative breast cancer: ten-year analysis--an intergroup study. J Clin Oncol (1998) 1.21
Hemin-mediated DNA strand scission. J Biol Chem (1983) 1.21
Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors. Biochem Pharmacol (1997) 1.20
Endocrine status of premenopausal node-positive breast cancer patients following adjuvant chemotherapy and long-term tamoxifen. Cancer Res (1988) 1.19
Clinical correlation between CEA and breast cancer. Cancer (1978) 1.19
Simple procedure for isolation of DNA, RNA and protein fractions from cultured animal cells. Anal Biochem (1975) 1.18
Alteration of endocrine parameters in premenopausal women with breast cancer during long-term adjuvant therapy with tamoxifen as the single agent. J Natl Cancer Inst (1991) 1.16
Control of globin gene expression by steroid hormones in differentiating Friend leukemia cells. Cell (1978) 1.15
Phase I study of vinblastine and verapamil given by concurrent iv infusion. Cancer Treat Rep (1985) 1.15
Early- and late-replicating deoxyribonucleic acid complexes in HeLa nuclei. Biochim Biophys Acta (1966) 1.14
12-O-tetradecanoylphorbol-13-acetate activates phosphatidylethanol and phosphatidylglycerol synthesis by phospholipase D in cell lysates. Biochem Biophys Res Commun (1988) 1.14
Tumor necrosis is a prognostic predictor for early recurrence and death in lymph node-positive breast cancer: a 10-year follow-up study of 728 Eastern Cooperative Oncology Group patients. J Clin Oncol (1993) 1.14
Steroid hormone receptors in normal human lymphocytes. Induction of glucocorticoid receptor activity by phytohemagglutinin stimulation. J Biol Chem (1977) 1.13
Combined chemotherapy and surgery in breast cancer: a review. Cancer (1975) 1.09
Nonbacterial pneumonitis with multidrug antineoplastic therapy in breast carcinoma. Can Med Assoc J (1973) 1.09
Evaluation of tamoxifen doses with and without fluoxymesterone in advanced breast cancer. Ann Intern Med (1983) 1.09
The bone marrow examination in breast cancer: diagnostic considerations and clinical usefulness. Cancer (1978) 1.08
Biological effects of transferrin on human lymphocytes in vitro. Exp Cell Res (1972) 1.07
Hemin inhibits virion-associated reverse transcriptase of murine leukemia virus. Biochem Biophys Res Commun (1987) 1.07
Animal model to study the relationship between immunoreactive gastrin and inflammatory arthritis. Nature (1974) 1.06
A ligand-induced conformational change in the estrogen receptor is localized in the steroid binding domain. Biochemistry (1992) 1.05
Venous thrombosis during multimodal treatment of primary breast carcinoma. Cancer Treat Rep (1981) 1.04
Actinomycin D and p-fluorophenylalanine, inhibitors of nuclear replication in HeLa cells. Biochim Biophys Acta (1966) 1.03
Biological markers in breast carcinoma. II. Clinical correlations with human chorionic gonadotrophin. Cancer (1977) 1.03
Endocrine effects of adjuvant chemotherapy and long-term tamoxifen administration on node-positive patients with breast cancer. Cancer Res (1987) 1.02
Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy. J Clin Oncol (1988) 1.02
A comparison of intermittent vs. continuous and of adriamycin vs. methotrexate 5-drug chemotherapy for advanced breast cancer. A Cancer and Leukemia Group B study. Am J Clin Oncol (1984) 1.02
Release of a lymphocyte growth promoter in leucocyte cultures. Nature (1968) 1.02
Evaluation of tamoxifen dose in advanced breast cancer: a progress report. Cancer Treat Rep (1976) 1.01
In vitro regulation of RNA polymerase in estrogen-treated uteri. Biochem Biophys Res Commun (1966) 0.99
DNA replication in nuclei isolated from bovine lymphocytes. Biochim Biophys Acta (1975) 0.99
Tamoxifen metabolites in patients on long-term adjuvant therapy for breast cancer. Eur J Cancer (1990) 0.99
Correlations between leukocyte count and absolute granulocyte count in patients receiving cancer chemotherapy. Cancer (1985) 0.98
The synthesis and assembly of DNA subunits in isolated HeLa cell nuclei. Biochem Biophys Res Commun (1969) 0.97
Malignant chemodectoma of the superior mediastinum with elevated urinary homovanillic acid. Chest (1974) 0.97
Monoclonal IgA and IgM in the serum of a single patient (SC). 3. Immunofluorescent identification of cells producing IgA and IgM. J Immunol (1973) 0.97
Long-term adjuvant therapy with tamoxifen: effects on sex hormone binding globulin and antithrombin III. Cancer Res (1987) 0.96
Changes in the activity of rat adrenal ribonuclease and ribonuclease inhibitor after administration of corticotrophin. Biochim Biophys Acta (1965) 0.96
The stepwise acceleration of phosphatidyl choline synthesis in phytohemagglutinin-treated lymphocytes. Biochim Biophys Acta (1969) 0.95
A role of estrogens in the regulation of RNA polymerase in surviving rat uteri. Biochim Biophys Acta (1968) 0.95
A permeable cell system for studying DNA replication in synchronized HeLa cells. Biochim Biophys Acta (1975) 0.94
The urinary excretion of nucleosides of ribonucleic acid by patients with advanced cancer. Cancer (1975) 0.94
Deoxyribonucleic acid chain growth and organization of replicating units in HeLa cells. Biochemistry (1977) 0.94
Studies on the nature of replicating DNA of HeLa cells. Biochim Biophys Acta (1969) 0.93
Adjuvant tamoxifen treatment of elderly women with stage II breast cancer. A double-blind comparison with placebo. Ann Intern Med (1985) 0.93
Phorbol esters activate the pathway for phosphatidylethanol synthesis in differentiating HL-60 cells. Biochim Biophys Acta (1987) 0.93
Long-term survival of patients treated with combination chemotherapy for metastatic breast cancer. Eur J Cancer (1991) 0.92
Binding of estrogen receptor to estradiol immobilized on insoluble resins. Biochim Biophys Acta (1969) 0.92
Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patients. J Clin Oncol (1992) 0.92
Ten-year follow-up study of premenopausal women with metastatic breast cancer: an Eastern Cooperative Oncology Group study. J Clin Oncol (1995) 0.92
Adjuvant trial of 12 cycles of CMFPT followed by observation or continuous tamoxifen versus four cycles of CMFPT in postmenopausal women with breast cancer: an Eastern Cooperative Oncology Group phase III study. J Clin Oncol (1990) 0.91
12-O-tetradecanoylphorbol-13-acetate activates the synthesis of phosphatidylethanol in animal cells exposed to ethanol. Carcinogenesis (1987) 0.91